Public Markets
4 stories covering public markets — fund closes, LP allocations, regulatory filings, deal flow, and fundraising signals from PipelineRoad's editorial team.
Electra Therapeutics raises $350M in upsized Nasdaq IPO for SIRP-targeting drugs
Electra Therapeutics priced an upsized IPO at $15 per share, raising $350 million and debuting on Nasdaq as ETRA to fund clinical research in precision immunology.
Authentic Brands Group could pursue IPO as early as first half of next year
Authentic Brands Group CEO Matthew Maddox said the licensing company is “ready to go” for an IPO, according to Dealbreaker citing Bloomberg TV.
KKR-backed Wella files for U.S. IPO; reports $2.94bn revenue for FY ended June 30, 2026
Wella Company filed for a U.S. IPO and reported $2.94 billion in revenue for the year ended June 30, 2026, according to Dealbreaker.
Crunchbase flags eight venture-backed startups as potential 2026 IPO candidates
Crunchbase News lists eight venture-backed startups it says have at least a 40% probability of going public within six months, as the 2026 IPO window narrows.
